Evenity 105Mg/1.17Ml (90Mg/ml) 2 Injection
EVENITY is a sclerostin inhibitor indicated for the treatment of osteoporosis
in postmenopausal women at high risk for fracture, defined as a history of
osteoporotic fracture, or multiple risk factors for fracture; or patients who
have failed or are intolerant to other available osteoporosis therapy.
in postmenopausal women at high risk for fracture, defined as a history of
osteoporotic fracture, or multiple risk factors for fracture; or patients who
have failed or are intolerant to other available osteoporosis therapy.
$163.56
Original: $545.21
-70%Evenity 105Mg/1.17Ml (90Mg/ml) 2 Injection—
$545.21
$163.56Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
EVENITY is a sclerostin inhibitor indicated for the treatment of osteoporosis
in postmenopausal women at high risk for fracture, defined as a history of
osteoporotic fracture, or multiple risk factors for fracture; or patients who
have failed or are intolerant to other available osteoporosis therapy.
in postmenopausal women at high risk for fracture, defined as a history of
osteoporotic fracture, or multiple risk factors for fracture; or patients who
have failed or are intolerant to other available osteoporosis therapy.
